Cardiosel Warnings

Concise Prescribing Info Full Prescribing Info Contents Description Action Indications/Uses Dosage/Direction for Use Overdosage Contraindications Warnings Special Precautions Use In Pregnancy & Lactation Adverse Reactions Drug Interactions Storage MIMS Class ATC Classification Regulatory Classification Presentation/Packing

Full Prescribing Info

Warnings

Ischemic Heart Disease: Exacerbations of angina pectoris, and in some cases, myocardial infarction have occurred after abrupt discontinuation of certain beta-blockers. Gradually reduce dosage over a period of 1 to 2 weeks and carefully monitor the patient when discontinuing chronically administered metoprolol, particularly in patients with ischemic heart disease. Metoprolol should promptly be reinstated, at least temporarily, and initiate other measures appropriate for the management of unstable angina if angina markedly worsens or acute coronary insufficiency develops. Patients should be warned against interruption or discontinuation of therapy without physician's advice. It may be prudent not to discontinue metoprolol abruptly even in patients treated only for hypertension since coronary artery disease is common and may be unrecognized.

metoprolol

Manufacturer:

Amherst Lab

Distributor:

UNILAB, Inc

Marketer:

Westmont